Smallcap Pharma Company NGL Fine Chem Sees -8.35% Drop in Stock Price on August 13th

NGL Fine Chem, a smallcap pharmaceutical company, saw a decline of -8.35% in its stock price on August 13th, 2024. This drop was in line with the overall performance of the sector, as the company underperformed by -8.6%. The stock opened with a loss of -4.91% and reached an intraday low of Rs 2252.85, a decrease of -14.31%.

According to MarketsMOJO, a leading stock analysis and recommendation platform, the current call for NGL Fine Chem's stock is 'Hold'. This is based on the company's recent performance and market trends.

In terms of moving averages, NGL Fine Chem's stock is currently higher than its 100-day and 200-day moving averages, but lower than its 5-day, 20-day, and 50-day moving averages. This indicates a mixed trend in the short term, but a positive trend in the long term.

Compared to the overall performance of the Sensex, NGL Fine Chem's stock has underperformed in the past 1 day and 1 month, with a decline of -7.88% and -6.07%, respectively. However, it is important to note that this is a smallcap company and its performance may not always align with the broader market trends.

Investors should keep an eye on NGL Fine Chem's stock and monitor its performance in the coming days. As always, it is important to do thorough research and consult with a financial advisor before making any investment decisions.